Trials / Completed
CompletedNCT03558425
A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects
A Randomized, Open-label, Multiple-dose, and Crossover Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of CKD-381 and D026 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
A Study to compare pharmacokinetics and safety of CKD-381 and D026 in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-381 | 1 tablet administered before the breakfast during 7 days |
| DRUG | D026 | 1 tablet administered before the breakfast during 7 days |
Timeline
- Start date
- 2018-06-27
- Primary completion
- 2018-09-14
- Completion
- 2018-09-14
- First posted
- 2018-06-15
- Last updated
- 2018-10-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03558425. Inclusion in this directory is not an endorsement.